Wells Fargo & Company Madrigal Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 29,319 shares of MDGL stock, worth $9.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,319
Previous 29,635 1.07%
Holding current value
$9.15 Million
Previous $8.3 Million 25.05%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$212.22 - $292.96 $67,061 - $92,575
-316 Reduced 1.07%
29,319 $6.22 Million
Q2 2024

Aug 13, 2024
BUY
$193.33 - $291.99 $2.48 Million - $3.74 Million
12,824 Added 76.28%
29,635 $8.3 Million
Q1 2024

May 10, 2024
SELL
$171.37 - $283.23 $7.36 Million - $12.2 Million
-42,974 Reduced 71.88%
16,811 $4.49 Million
Q4 2023

Feb 09, 2024
BUY
$120.4 - $237.13 $4.78 Million - $9.41 Million
39,672 Added 197.25%
59,785 $13.8 Million
Q3 2023

Nov 13, 2023
BUY
$146.04 - $225.78 $86,747 - $134,113
594 Added 3.04%
20,113 $2.94 Million
Q2 2023

Aug 15, 2023
BUY
$203.88 - $312.0 $709,094 - $1.09 Million
3,478 Added 21.68%
19,519 $4.51 Million
Q1 2023

May 12, 2023
SELL
$231.06 - $307.08 $2.19 Million - $2.91 Million
-9,487 Reduced 37.16%
16,041 $3.89 Million
Q4 2022

Feb 13, 2023
SELL
$58.39 - $296.54 $24,815 - $126,029
-425 Reduced 1.64%
25,528 $7.41 Million
Q3 2022

Nov 14, 2022
SELL
$60.57 - $79.51 $378,865 - $497,335
-6,255 Reduced 19.42%
25,953 $1.69 Million
Q2 2022

Aug 12, 2022
BUY
$58.04 - $100.2 $453,002 - $782,061
7,805 Added 31.98%
32,208 $2.31 Million
Q1 2022

May 16, 2022
SELL
$55.89 - $101.89 $206,848 - $377,094
-3,701 Reduced 13.17%
24,403 $2.39 Million
Q4 2021

Feb 14, 2022
SELL
$72.34 - $95.09 $40,582 - $53,345
-561 Reduced 1.96%
28,104 $2.38 Million
Q3 2021

Nov 15, 2021
SELL
$78.35 - $105.02 $180,596 - $242,071
-2,305 Reduced 7.44%
28,665 $2.29 Million
Q2 2021

Aug 16, 2021
SELL
$97.2 - $137.59 $289,753 - $410,155
-2,981 Reduced 8.78%
30,970 $3.02 Million
Q1 2021

May 13, 2021
SELL
$108.54 - $125.2 $1.08 Million - $1.24 Million
-9,940 Reduced 22.65%
33,951 $3.97 Million
Q4 2020

Feb 09, 2021
BUY
$110.06 - $133.7 $3.96 Million - $4.81 Million
36,007 Added 456.71%
43,891 $4.88 Million
Q3 2020

Nov 05, 2020
SELL
$99.78 - $124.21 $186,189 - $231,775
-1,866 Reduced 19.14%
7,884 $936,000
Q2 2020

Aug 13, 2020
BUY
$60.13 - $125.71 $103,183 - $215,718
1,716 Added 21.36%
9,750 $1.1 Million
Q1 2020

May 14, 2020
BUY
$66.76 - $93.49 $536,349 - $751,098
8,034 New
8,034 $537,000

Others Institutions Holding MDGL

# of Institutions
297
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.34B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email